UK Reduces Fines On Paroxetine Pay-For-Delay
But Competition Appeal Tribunal Upholds CMA Infringement Decision
Fines imposed on firms including Actavis, Alpharma, Generics UK and Xellia as well as GlaxoSmithKline have been reduced following Competition Appeal Tribunal ruling that nevertheless upheld a finding of competition law infringement linked to historical pay-for-delay deals.
